Evidence map›Paper›PMID 41530208›Full record

ArticleScientific reports2026

Influence of endogenous estrogen exposure on the development of hypertension in a cohort study using multistate model analysis.

Maryam Mousavi, Fahimeh Ramezani Tehrani, Fereidoun Azizi, Maryam Farahmand

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Maryam MousaviReproductive Endocrinology Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, 24 Parvaneh St, Yaman St, Velenjak, PO Box 19395-4763, Tehran, Iran.
Fahimeh Ramezani TehraniReproductive Endocrinology Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, 24 Parvaneh St, Yaman St, Velenjak, PO Box 19395-4763, Tehran, Iran.
Fereidoun AziziEndocrine Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Maryam FarahmandReproductive Endocrinology Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, 24 Parvaneh St, Yaman St, Velenjak, PO Box 19395-4763, Tehran, Iran. farahmand@sbmu.ac.ir.ORCID http://orcid.org/0000-0002-1748-5687

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The protective effect of endogenous estrogen exposure (EEE) duration on hypertension (HTN) risk was shown previously. This study aimed to investigate the effect of EEE on the transitions of different blood pressure (BP) states using a multi-state Markov model. At the study initiation, 2911 normotensive women aged ≥ 20 years were eligible. The Multi-state Markov model, a robust statistical tool, was used to explore the transition probability of various HTN stages, including (I) normotensive to pre-HTN, (II) normotensive to HTN, and (III) pre-HTN to HTN. At the end of the follow-up of 2911normotensive women, 1544 (53%) and 78 (2%) developed pre-HTN and HTN, respectively. The protective effect of EEE duration was observed in all HTN transitions. The most protective effect was observed in transition II [hazard ratio: 0.53; 95% confidence interval (CI): 0.42, 0.66]. Meanwhile, this protective effect in transitions I and III was 11% (95% CI: 0.82, 0.97) and 21% (95% CI: 0.68, 0.91), respectively. Age and family history of HTN were confounding variables that significantly increased the risk of BP progression across all three transitions. An elevated body mass index and a history of diabetes mellitus were found to increase the risk of HTN progression in transition I and II, respectively. The findings indicate that a prolonged duration of EEE was associated with a protective effect against HTN risk across all HTN progression transitions. Furthermore, individuals with shorter EEE durations may warrant closer monitoring due to their elevated risk of transitioning from normotensive to hypertensive states.

Indexed as

EstrogensHypertensionAdultBlood PressureCohort StudiesDisease ProgressionFemaleHumansMarkov ChainsMiddle AgedRisk FactorsEstrogensBlood pressureEndogenous estrogenMulti-state Markov modelTehran Lipid and Glucose Study (TLGS)

Identifiers

PMID41530208
PMCPMC12800285

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.